A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
Clinical trial NCT04533529 · COMPLETED
Trial details
- NCT number
- NCT04533529
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2023-04-25
- Enrollment
- 588
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.